Taysha Gene Therapies Inc (TSHA) Insider Trading
- $22,817,372.67
- $952,258.66
- June 27, 2024
- Paul B Manning
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| June 27, 2024 | Major Shareholder | 1,333,333 | $2.25 | Buy | $2,999,999.25 | |
| Nov. 17, 2023 | Major Shareholder | 100,000 | $1.63 | Buy | $163,000.00 | |
| Aug. 24, 2023 | CFO | 33,000 | $2.33 | Sell | $76,890.00 | |
| Aug. 16, 2023 | Director | 388,889 | $0.90 | Buy | $350,000.10 | |
| Aug. 16, 2023 | Major Shareholder | 16,466,667 | $0.90 | Buy | $14,820,000.30 | |
| Aug. 16, 2023 | CEO | 444,444 | $0.90 | Buy | $399,999.60 | |
| July 12, 2023 | Major Shareholder | 80,528 | $0.71 | Sell | $57,174.88 | |
| June 22, 2023 | Major Shareholder | 10,508 | $0.70 | Sell | $7,355.60 | |
| June 20, 2023 | Major Shareholder | 295,653 | $0.71 | Sell | $209,913.63 | |
| May 16, 2023 | Insider | 5,000 | $0.68 | Buy | $3,400.00 | |
| Oct. 31, 2022 | Director | 1,500,000 | $2.00 | Buy | $3,000,000.00 | |
| Aug. 22, 2022 | CFO | 9,717 | $3.50 | Sell | $34,009.50 | |
| Aug. 18, 2022 | CFO | 7,476 | $3.87 | Sell | $28,932.12 | |
| July 5, 2022 | CMO | 3,905 | $3.51 | Sell | $13,706.55 | |
| July 1, 2022 | CMO | 23,923 | $3.53 | Sell | $84,448.19 | |
| June 29, 2022 | CMO | 12,324 | $3.81 | Sell | $46,954.44 | |
| Feb. 2, 2022 | Director | 3,000 | $7.78 | Buy | $23,340.00 | |
| Nov. 23, 2021 | Director | 20,000 | $12.54 | Buy | $250,800.00 | |
| Nov. 23, 2021 | CEO | 42,518 | $12.44 | Buy | $528,923.92 | |
| Aug. 20, 2021 | CFO | 11,840 | $16.78 | Sell | $198,675.20 | |
| Aug. 18, 2021 | CFO | 11,193 | $17.35 | Sell | $194,198.55 | |
| May 20, 2021 | Director | 1,170 | $22.35 | Buy | $26,149.50 | |
| May 14, 2021 | Director | 12,000 | $20.98 | Buy | $251,760.00 |
Insiders are both buying and selling Taysha Gene Therapies Inc stock.
The insider traders at Taysha Gene Therapies Inc are: Paul B Manning, Kamran Alam, R.A. Session II, Suyash Prasad, Sean P Nolan, Phillip B Donenberg, Sukumar Nagendran, and John A Stalfort III
The most active insider trader at Taysha Gene Therapies Inc is Paul B Manning with 6 trades.
Kamran Alam has sold the most Taysha Gene Therapies Inc stock with a total value of $609,595.37.
Paul B Manning has bought the most Taysha Gene Therapies Inc stock with a total value of $24,485,558.80.
The most recent insider trade for Taysha Gene Therapies Inc was on June 27, 2024.
The single biggest insider buy for Taysha Gene Therapies Inc was from Paul B Manning with a total value of $14,820,000.30 on Aug. 16, 2023.
The single biggest insider sell for Taysha Gene Therapies Inc was from R.A. Session II with a total value of $209,913.63 on June 20, 2023.